Pluscor is developed by Heart Care Foundation.

What development phase is Pluscor in?

Pluscor is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Pluscor

Heart Care Foundation · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Pluscor
Sponsor	Heart Care Foundation
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Pluscor CI brief — competitive landscape report
Pluscor updates RSS · CI watch RSS
Heart Care Foundation portfolio CI